Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.0010 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 4:30 PM 12/10/14 All times are local (Market data is delayed by at least 15 minutes).

biosign technologies inc (BITKF) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/9/14 - $0.03
52 Week Low
12/10/14 - $0.0010
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

biosign technologies inc (BITKF) Related Businessweek News

No Related Businessweek News Found

biosign technologies inc (BITKF) Details

Biosign Technologies Inc. operates as a medical device and healthcare information technology company. It provides software platforms for delivering noninvasive gathering, analysis, and reporting of critical vital signs and biological parameters. The company’s products include Pulsewave, a health monitor device for displaying heart rate, blood pressure, pulse variability and respiration rate, and heart beat anomaly score; Pulsewave MAX, a prototype health monitor application; and Healthanyware, a patient monitoring/self-care platform. It also offers ClinicServer, an Internet based real time software platform used to manage various aspects of a clinic comprising scheduling, billing, and patient care; and PencilThat, an Internet-based self-scheduling application. In addition, the company provides various cardiovascular screening programs under the Heart Friendly Practice, Heart Friendly Dentist, and Heart Friendly Fitness brand names. Biosign Technologies Inc. was incorporated in 2004 and is based in Mississauga, Canada.

biosign technologies inc (BITKF) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

biosign technologies inc (BITKF) Key Developments

Biosign Technologies Inc. Proposes Amendments to its Articles of Association

Biosign Technologies Inc. proposed amendment to the articles of association, at the annual general meeting to be held on May 5, 2015.

Biosign Technologies Inc. Secures License Sale with the Release of an Enterprise Version of its Clinic Management Software

Biosign Technologies Inc. announced that it has signed an initial one year user-based network license agreement with a substantial multi-national corporation, consisting of a large network of physiotherapy, paramedical and rehab clinics and an associated technology services group. Under this contract Biosign will host the new Enterprise Version of its cloud-based ClinicServer practice management solution. The release of the Enterprise Version will significantly expand the market for the ClinicServer practice management solution. This innovative cloud solution will empower new customer to manage its complex multi-jurisdictional clinical operations from a centralized and unified technology base. Use of this Enterprise Version will substantially increase their operational efficiencies and also facilitate a new level of electronic payment processing into their expanding network of clinics. The customer has over 1500 clinics in its group of companies and solution is currently being rolled-out to the North American division over the next two months. The new ClinicServer Enterprise Version moves the product to a whole new plane and affirms Biosign/ClinicServer as a market-leading cloud-based practice management provider. The Enterprise Version was designed to deal with the unique challenges associated with the management and administration of the day-to-day operations of hundreds or thousands of clinical locations and features brand reporting capabilities, billing and eClaims modules.

Biosign Technologies Inc. Converts Demand Loans Payable to Quindell Solutions Inc

Biosign Technologies Inc. announced that the demand loans payable to Quindell Solutions Inc. totaling $6.8 million plus all accrued interest of circa $180,000 have been converted to a loan repayable over a period of 5 years. The Term Loan accrues interest at the rate of 2% per annum above prime rate. The first payment of $1,360,000 together with interest is due in December 2015 and subsequent payments of $680,000 together with interest are due every six months thereafter. The final payment in December 2019 will also include the Accrued Interest.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BITKF:US $0.00 USD 0.00

BITKF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BITKF.
View Industry Companies

Industry Analysis


Industry Average

Valuation BITKF Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 493.4x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 192.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOSIGN TECHNOLOGIES INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at